Methylenedioxyethylamphetamine

From Wikipedia, the free encyclopedia
Methylenedioxyethylamphetamine
Systematic (IUPAC) name
1-(1,3-benzodioxol-5-yl)-N-ethyl-propan-2-amine
Clinical data
Legal status Schedule I (US)
Identifiers
CAS number 82801-81-8
ATC code ?
PubChem CID 105039
ChemSpider 94775
Chemical data
Formula C12H17NO2 
Mol. mass 207.27 g/mol

MDEA (3,4-methylenedioxy-N-ethylamphetamine; MDE, "Eve") is a psychedelic and entactogenic drug of the phenethylamine and amphetamine chemical classes.

Like MDA, MDEA acts as a serotonin, norepinephrine, and dopamine releasing agent.[1][2][3]

The subjective effects of MDEA are very similar to those of MDMA. However, the euphoric and "loved up" feelings associated with MDMA are not as pronounced in comparison. The effects of MDEA are also not as stimulating as MDMA, as it is said to be somewhat stoning in high doses and may be responsible for rumors of heroin-laced "ecstasy" tablets.

See also

References

  1. Freudenmann RW, Spitzer M. The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA). CNS Drug Reviews. 2004 Summer;10(2):89-116. PMID 15179441
  2. http://www.erowid.org/chemicals/mde/mde_info2.shtml
  3. Erowid Online Books : "PiHKAL" - #106 MDE

External links

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.